Silence Therapeutics plc

NasdaqGM:SLN Stock Report

Market Cap: US$331.0m

Silence Therapeutics plc Company Information

Silence Therapeutics plc's employee growth, exchange listings and data sources

Key Information

  • Name: Silence Therapeutics plc
  • Ticker: SLN
  • Exchange: NasdaqGM
  • Founded: 1994
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$330.976m
  • Shares Outstanding: 47.21m
  • Website: https://www.silence-therapeutics.com

Number of Employees

Location

  • Silence Therapeutics plc
  • 72 Hammersmith Road
  • London
  • Greater London
  • W14 8TH
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SLNC.FOTCPK (Pink Sheets LLC)Ordinary SharesUSUSDApr 1995
XRP2DB (Deutsche Boerse AG)YesADSDEEURSep 2020
SLNNasdaqGM (Nasdaq Global Market)YesADSUSUSDSep 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 04:03
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.